Product information

Xolair 150 mg
1 ml
omalizumab
2687408
3.68 / 10
Locked

Product properties

242138-07-4
R03DX05
Novartis Europharm
Solution for injection
€204.93
EU/1/05/319/024
07613421103552
M42
Public
662007-01

Pharmacist Assessment

Discontinued product — remaining stock available

The commercialization of this product has been stopped (reason: Vervanging door een ander geneesmiddel/verpakking), but remaining stock is available at wholesalers (score 3.68/10). This stock will not be replenished. Plan the switch to an alternative.

Recommended alternative

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 10 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Active
- present

Vervanging door een ander geneesmiddel/verpakking

Alternative available

Composition

2 ingredients

Substance Type Strength CAS
Active ingredient
150 mg/mL
242138-07-4
Excipient

Additional information

Availability statistics

Commercialization stopped
364 days
3
0
31/03/2025